A5-A dual-target antiviral compound that rewrites the rules of influenza therapy.

Author: Shibo JIANG ¹
Author Information

1. Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Publication Type:Editorial
Keywords: Dual-target therapy; Influenza; RNA-dependent RNA polymerase
From: Acta Pharmaceutica Sinica B 2025;15(8):4322-4323
CountryChina
Language:English